Recall all batches of MIMPARA 30MG F.C. TABLETS and MIMPARA 60MG F.C. TABLETS
2024-08-04
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer MIMPARA 30MG F.C. TABLETS CINACALCET 30 MG 13-475-08 جميع التشغيلات PATHEON MIMPARA 60MG F.C. TABLETS CINACALCET 60MG 14-475-08
التصنيف
ملف
التاريخ
2024-07-31
اسم المستحضر
MIMPARA 30MG F.C. TABLETS & MIMPARA 60MG F.C. TABLETS
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall all batches of MIMPARA 30MG F.C. tablets and MIMPARA 60MG F.C. products due to the affected batches are not comply with the required specifications. AMGEN EUROPE B.V. is voluntarily recalling all batches of the above products.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.